
Researchers are using AI-enabled Raman spectroscopy to enhance the development, administration, and response prediction of cancer immunotherapies. This innovative, label-free method provides detailed insights into tumor-immune microenvironments, aiming to optimize personalized immunotherapy and other treatment strategies and improve patient outcomes.



























